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A B S T R A C T
Background
The timing of surgery for recently symptomatic carotid artery stenosis remains controversial. Early cerebral revascularization may
prevent a disabling or fatal ischemic recurrence, but it may also increase the risk of hemorrhagic transformation, or of dislodging a
thrombus. This review examined the randomized controlled evidence that addressed whether the increased risk of recurrent events
outweighed the increased benefit of an earlier intervention.
Objectives
To assess the risks and benefits of performing very early cerebral revascularization (within two days) compared with delayed treatment
(after two days) for people with recently symptomatic carotid artery stenosis.
Search methods
We searched the Cochrane Stroke Group Trials Register in January 2016, the Cochrane Central Register of Controlled Trials (CEN-
TRAL; The Cochrane Library 2016, Issue 1), MEDLINE (1948 to 26 January 2016), EMBASE (1974 to 26 January 2016), LILACS
(1982 to 26 January 2016), and trial registers (from inception to 26 January 2016). We also handsearched conference proceedings and
journals, and searched reference lists. There were no language restrictions. We contacted colleagues and pharmaceutical companies to
identify further studies and unpublished trials.
Selection criteria
All completed, truly randomized trials (RCT) that compared very early cerebral revascularization (within two days) with delayed
treatment (after two days) for people with recently symptomatic carotid artery stenosis.
Data collection and analysis
We independently selected trials for inclusion according to the above criteria, assessed risk of bias for each trial, and performed data
extraction. We utilized an intention-to-treat analysis strategy.
1Immediate versus delayed treatment for recently symptomatic carotid artery stenosis (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Main results
We identified one RCT that involved 40 participants, and addressed the timing of surgery for people with recently symptomatic carotid
artery stenosis. It compared very early surgery with surgery performed after 14 days of the last symptomatic event. The overall quality
of the evidence was very low, due to the small number of participants from only one trial, and missing outcome data. We found no
statistically significant difference between the effects of very early or delayed surgery in reducing the combined risk of stroke and death
within 30 days of surgery (risk ratio (RR) 3.32; confidence interval (CI) 0.38 to 29.23; very low-quality evidence), or the combined
risk of perioperative death and stroke (RR 0.47; CI 0.14 to 1.58; very low-quality evidence). To date, no results are available to confirm
the optimal timing for surgery.
Authors’ conclusions
There is currently no high-quality evidence available to support either very early or delayed cerebral revascularization after a recent
ischemic stroke. Hence, further randomized trials to identify which patients should undergo very urgent revascularization are needed.
Future studies should stratify participants by age group, sex, grade of ischemia, and degree of stenosis. Currently, there is one ongoing
RCT that is examining the timing of cerebral revascularization.
P L A I N L A N G U A G E S U M M A R Y
Timing of treatment for people with recent symptoms from neck artery narrowing
Background
Ischemic stroke occurs when blood flow is blocked from part of the brain. This can be caused by a disease in the neck (carotid) artery
that can cause a severe narrowing of the artery, leading to blood clot formation and blockage of a smaller blood vessel downstream.
Opening up the carotid artery can reestablish adequate blood flow by surgical removal of the diseased area, or by inserting a tube (stent)
to open the artery.
There is uncertainty about whether to perform the treatment immediately, or to wait a few days. Early treatment can improve blood
flow, and prevent new strokes. However, early treatment may carry a higher risk of causing a stroke or associated bleeding.
Review question
We reviewed the effectiveness of performing very early treatment (within two days) compared with delayed treatment (after two days)
for individuals with recent symptoms from neck (carotid) artery narrowing.
Study characteristics
The searches are up-to-date to 26 January 2016. We found only one randomized trial that assessed the effect of the timing of surgery.
It included a total of 40 participants, ranging in age from 47 to 84 years.
Key results
From the limited evidence available, we cannot tell if the timing of surgery is an important factor in determining the outcome for
individuals with recent symptoms from carotid artery narrowing.
Quality of the evidence
There is not enough evidence on the best time for surgical treatment for people with recent symptoms from carotid artery narrowing.
The overall quality of the evidence was very low, due to the small number of participants from only one trial and missing outcome
data. Further studies with a larger number of patients are needed.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Very early cerebral revascularization compared with delayed treatment for recently symptomatic carotid artery stenosis
Patient or population: people with recent ly symptomatic carot id artery stenosis
Settings: hospital
Intervention: very early cerebral revascularizat ion (within two days)
Comparison: delayed treatment (af ter two days)
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Very early cerebral
revascularization
Delayed Treatment
Stroke and Death < 30
days
This outcome was poorly reported RR 3.3 (0.4 to 29.2) 40 (1 study) ©©©
very low1,2,3
Perioperative death
and strokes
This outcome was poorly reported RR 0.5 (0.1 to 1.6) 40 (1 study) ©©©
very low1,2,3
Lenght of hospital stay This outcome was poorly reported: One study reported no dif ference between groups. No standard deviat ion was reported
M yocardial infarction <
30 days
This outcome was not reported
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; RR: Risk Ratio;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
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1Downgraded one level: one study with small sample size
2Downgraded one level due to risk of bias: incomplete outcome data
3Downgraded one level due to uncertainty in outcome measurement
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B A C K G R O U N D
Description of the condition
Annually, approximately 15 million people have a stroke world-
wide, and 5.5 million of them die as a result of the event (Mackay
2004). Approximately 88% of all strokes are ischemic (Park 2012),
and thromboembolism from an atheromatous plaque in the ex-
tracranial carotid artery has been determined to be the sole cause of
stroke or a transient ischemic attack (TIA) in about 8% (Flaherty
2013; Park 2012). The risk of developing a future cerebrovascular
ischemic event is related to inadequate cerebral blood perfusion
as a result of hemodynamic stenosis, or plaque rupture and ob-
struction of smaller, more distally located blood vessels (Mokin
2013). In people with a recent cerebral or ocular ischemic episode,
in whom the relevant (i.e. symptomatic) carotid artery is patent
but the atheroma has caused a stenosis, some type of revasculariza-
tion proceduremay be required. According to different guidelines,
surgical revascularization is recommended for people with symp-
tomatic 50% to 99% carotid artery stenosis (Brott 2011; Kakisis
2012; Ricotta 2011). Carotid revascularization can be achieved
by carotid endarterectomy or carotid artery stenting. The effec-
tiveness of carotid endarterectomy for stroke prevention in people
with symptomatic extracranial carotid disease has been established
in randomized controlled trials (RCTs; Rothwell 2003). Angio-
plasty with stenting has emerged as an alternative, less invasive
therapeutic method of treating all patients with carotid disease,
with the increased risk of periprocedural stroke or death limited
to older patients (Bonati 2012).
Description of the intervention
Since the 1950s, when carotid endarterectomy was introduced as
an option for treatment and prevention of stroke, the number of
procedures has increased (Rerkasem 2011). Carotid revasculariza-
tion can reestablish adequate blood flow by removal of a critical
carotid stenosis; this can be accomplished by surgical or endovas-
cular treatment. Surgical options comprise conventional and ev-
ersion carotid endarterectomy. Conventional carotid endarterec-
tomy is achieved by a longitudinal carotid arteriotomy with patch
angioplasty, whereas eversion carotid endarterectomy involves a
transection of the internal carotid artery and reimplantation into
the common carotid artery (Antonopoulos 2011; Ricotta 2011).
Clamping of the carotid arteries is required for removal of the
plaque in both techniques (Kakisis 2012).
Furthermore, endovascular treatment may be a useful alternative
to carotid endarterectomy. Carotid artery stenosis can be treated
after a catheter inserted into the femoral artery is advanced, and
after the target vessel lesion has been crossed, by deploying a self-
expanding stent to cover the entire lesion (Kakisis 2012). Several
embolic protection systems, including filters and flow arrest and
reversal devices, have been developed in an attempt to reduce the
chances of cerebral embolization (Paraskevas 2016). In addition,
a transcervical approach carotid artery stenting using flow reversal
protection has also been described (EMPIRE 2011).
How the intervention might work
The timing of revascularization of symptomatic internal carotid
artery stenosis has changed over the years. Rothwell 2003 showed
greater benefit of surgery when performed within 14 days of the
last symptomatic event. However, no definite time lag has been
observed between occurrence of the neurologic event and surgery.
Early revascularization is beneficial for symptomatic patients be-
cause this intervention may prevent a disabling or fatal stroke, but
an early intervention may increase perioperative risk of stroke and
death from carotid revascularization (Capoccia 2012; Imai 2005;
Rantner 2011).
An ischemic stroke recurrence and perioperative risks of revascu-
larization have very different mechanisms (Rerkasem 2011). The
presumption is that early revascularization will improve perfusion
to a large territory at risk surrounding an infarct core (i.e. the
penumbra), will recruit brain areas before cell death occurs, and
will prevent new embolic events (Capoccia 2011; Ricotta 2011).
Major concerns about early revascularization after TIA or stroke
include the following:
• Transformation of the preexisting infarct core into a
hemorrhagic lesion as a result of reperfusion or hyperperfusion
injury (Ferrero 2014; Tsivgoulis 2014);
• Increased vulnerability of recently infarcted brain tissue to
periprocedural cerebral ischemia induced by carotid clamping or
profoundly decreased blood pressure (Tsivgoulis 2014);
• Increased vulnerability of carotid plaques in the early phase
of cerebral ischemia and thus hazardous removal without distal
embolization (Strömberg 2012; Tsivgoulis 2014).
On one hand, the danger of delaying investigation and treatment
after a TIA or a nondisabling stroke depends on the early risk of
ischemic recurrence (Lovett 2003; Rantner 2011). Early risk of
stroke after aTIAor a non-disabling stroke is around3.1% to5.2%
within 48 hours; this increases to 8.3% to 11.2% at 14 days (Giles
2007; Johansson 2013; Marnane 2011). On the other hand, the
risk of hemorrhagic transformation or of dislodging a thrombus
is a matter of major concern during the early intervention. All
major adverse events and vascular complications that occur within
30 days of the procedure are attributed to the procedure. Within
30 days of endarterectomy, the risk of death or stroke is 2.4% to
7.6% within 48 hours, and 0.8% to 6.9% at 14 days (Halm 2009;
Johansson 2013; Rantner 2013; Sharpe 2013).
In addition, carotid artery stenting has a periprocedural stroke
and death risk of 7.1% within 48 hours of a neurologic event,
and 2.8% to 8.1% at 14 days (Rantner 2013; Wach 2014). The
theoretical benefit of early carotid artery stenting is that it provides
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the possibility of reopening a critical stenosis with rare reduction in
cerebral blood flow (Imai 2005). However, carotid artery stenting
within the first few days of a neurologic event may carry excessive
risk of mobilization of a thrombus (Rantner 2013).
Why it is important to do this review
The inability to predict which patients may have neurologic wors-
ening during the first 24 to 48 hours after stroke may explain the
variation in management of acute stroke among physicians and
institutions (Battocchio 2012; Ferrero 2014).
In the UK, current guidelines recommend that carotid interven-
tion should ideally be performedwithin two days for symptomatic
severe carotid stenosis in stable patients (as cited inCapoccia 2011;
Strömberg 2012). In the USA, it is recommended that carotid
endarterectomy should be performed within two weeks of the
neurologic event, and urgent revascularization may be considered
for stable patients who have limited areas of infarct with a large
penumbra (Ricotta 2011).
Analysis of RCTs is necessary to determine whether increased risk
of recurrent events outweighs the increased risk of an earlier inter-
vention. Reliable data on risk of surgery or carotid artery stenting
in relation to timing of the intervention are necessary if clinicians
are to plan surgery or carotid artery stenting most effectively, to
adjust risks for case-mix, and to understand the mechanisms of
operative stroke.
O B J E C T I V E S
To assess the risks and benefits of performing very early cerebral
revascularization (within two days) compared with delayed treat-
ment (after two days) for people with recently symptomatic carotid
artery stenosis.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included RCTs that compared early intervention versus
delayed revascularization in people with recently symptomatic
carotid artery stenosis (up to 14 days fromonset of symptoms).We
included studies only if data on clinically significant endpoints,
such as ischemic stroke, hemorrhagic stroke, or death, were avail-
able.
Types of participants
We included people who had suffered a recent neurologic (TIA or
stroke) event ipsilateral to stenosis of 50% to 99% in the carotid
artery. We defined a stroke as any cerebrovascular or retinal event
with symptoms lasting longer than 24 hours (Rerkasem 2011;
Rothwell 2003), and a TIA as a focal neurologic deficit lasting
24 hours (Ferrero 2014; Giles 2007). We defined a nondisabling
stroke as a stroke that resulted in no disability of functional signif-
icance (modified Rankin score < 3; Brott 2011; Rerkasem 2011;
Rothwell 2003).
Brain imaging that demonstrated a new lesion involving a different
anatomic site or vascular territory from the index event could be
used to support the diagnosis of perioperative stroke.We classified
strokes as disabling or nondisabling (as defined by trial authors),
fatal or nonfatal, or contralateral, ipsilateral, hemorrhagic, or is-
chemic.
Types of interventions
All techniques aimed at revascularization in symptomatic carotid
artery stenosis, including but not confined to:
• percutaneous transluminal balloon angioplasty and
stenting;
• carotid endarterectomy; and
• carotid eversion.
We included randomized studies comparing early intervention
(within two days) versus delayed treatment (after two days).
Types of outcome measures
Primary outcomes
• The combined outcome of any stroke or death occurring
within 30 days of surgery or endovascular treatment
(postoperative).
Secondary outcomes
• Myocardial infarction within 30 days of surgery.
• Myocardial infarction within 30 days of endovascular
treatment.
• Strokes or deaths, or both, during the perioperative period.
For the purposes of this review the term perioperative refers to
the three phases of surgery: preoperative, intraoperative, and
postoperative, and commonly includes ward admission,
anesthesia, surgery, and recovery.
• Duration of procedures, length of hospital stay, and
procedure-related costs (if data are available).
• Significant local complications related to revascularization,
such as access site hematoma, infection, cranial nerve palsy, or
pseudoaneurysm formation.
6Immediate versus delayed treatment for recently symptomatic carotid artery stenosis (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Myocardial infarction is defined by the presence of two of the
following criteria:
• Specific cardiac enzymes more than twice the upper limit of
normal;
• History of chest discomfort lasting at least 30 minutes;
• Development of specific abnormalities on a standard 12-
lead electrocardiogram (ECG).
Search methods for identification of studies
See the ’Specialized register’ section in the Cochrane Stroke Group
module. We searched for relevant trials published in all languages
and arranged translation of trial reports if required.
Electronic searches
We searched the Cochrane Stroke Group’s Trials Register (
strokecenter.org/trials) and the following electronic databases and
trials registers:
• The Cochrane Central Register of Controlled Trials
(CENTRAL; The Cochrane Library 2016, Issue 1; Appendix 1);
• MEDLINE (Ovid; 1948 to 26 January 2016; Appendix 2);
• EMBASE (Ovid; 1948 to 26 January 2016; Appendix 3);
• Literatura Latino-Americana e do Caribe em Ciências da
Saúde (LILACS; 1948 to 26 January 2016; Appendix 4);
• ClinicalTrials.gov (clinicaltrials.gov)
• Current Controlled Trials (controlled-trials.com)
• European Union (EU) Clinical Trials Register (
clinicaltrialsregister.eu)
• World Health Organization (WHO) International Clinical
Trials Registry Platform (apps.who.int/trialsearch)
We developed the MEDLINE search strategy with the help of the
Cochrane Stroke Group Information Specialist and modified it
for use with the other databases.
Searching other resources
In an effort to identify further published, unpublished, and ongo-
ing trials, we:
• searched the reference lists of identified studies and reviews;
• contacted study authors and experts in the field;
• contacted relevant pharmaceutical companies; and
• used Science Citation Index Cited Reference Search for
forward tracking of important articles.
Data collection and analysis
Selection of studies
Two review authors (VV and NC) independently screened titles
and abstracts of the references obtained as a result of our searching
activities and excluded obviously irrelevant reports. We retrieved
full-text articles for the remaining references, and two review au-
thors (VV and NC) independently screened the full-text articles,
identified studies for inclusion, and identified and recorded rea-
sons for exclusion of ineligible studies. We resolved disagreements
through discussion; if required, we consulted a third review au-
thor (JCCBS) for resolution. We collated multiple reports on the
same study, so that each study, not each reference, was the unit
of interest in the review. We recorded the selection process and
completed a PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) flow diagram (Figure 1).
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Figure 1. Study flow diagram.
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Data extraction and management
Two review authors (VV and NC) independently extracted the
following data from eligible studies and recorded this information
on standard data extraction forms:
• Participants: sample size, age, sex, number of participants
originally allocated to each treatment group, diagnostic criteria
used for carotid stenosis, number of participants in each group
with early or delayed intervention.
• Intervention: time interval from onset of symptoms of TIA
or stroke to randomization, and from randomization to surgery,
type of anesthesia, technique of carotid endarterectomy,
technique of carotid artery stenting, any other major vascular
surgery.
• Outcomes: number of participants in each group with
outcome events, including stroke, myocardial infarction, and
death.
• Withdrawals and adverse effects.
• Length of follow-up.
• Additional important information.
We resolved disagreements between review authors by discussion.
Assessment of risk of bias in included studies
Two review authors (VV and NC) independently assessed risk
of bias for each study using the criteria outlined in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
We resolved disagreements by discussion or by involving another
review author (JCCBS).We assessed the following domains as ’Yes’
(low risk of bias), ’Unclear’ (uncertain risk of bias) or ’No’ (high
risk of bias):
• Random sequence generation: was the sequence generation
adequate?
• Allocation concealment: was allocation adequately
concealed?
• Blinding of participants and personnel: were participants
and personnel blinded to the allocated interventions?
• Blinding of outcome assessment: were the outcome
assessors blinded to the allocated interventions?
• Incomplete outcome data: were incomplete outcome data
adequately addressed and similar across intervention groups?
• Selective outcome reporting: are reports of the study free of
the suggestion of selective outcome reporting?
• Other bias: was the study apparently free of other problems
that could put it at a risk of bias?
We graded the risk of bias for each domain as high, low, or unclear
and provided information from the study report together with a
justification for our judgment in the ’Risk of bias’ tables.
Measures of treatment effect
For dichotomous variables, we calculated risk ratios (RRs) and
95% confidence intervals (CIs). For continuous data, we would
have calculated mean differences (MDs) and 95% CIs between
treatment groups if studies reported exactly the same outcomes.
If similar outcomes were reported on different scales, we would
have calculated the standardized mean difference (SMD) and the
95%CI. Themost appropriate way of summarizing time-to-event
data would have been to use methods of survival analysis while
expressing the intervention effect as a hazard ratio; we extracted
these data directly from the results of studies (Higgins 2011).
Unit of analysis issues
We based the unit of analysis on the individual participant (unit
randomized for interventions to be compared; i.e. the number of
observations in the analysis should have matched the number of
individuals randomly assigned).
Dealing with missing data
For missing or unavailable data, we contacted study authors to re-
quest additional information. If we received no response, regard-
less of the type of data, we had planned to report dropout rates
in the ’Characteristics of included studies’ tables of the review,
and use intention-to-treat analysis (Higgins 2011). Therefore, we
included all randomized participants in the groups to which they
were allocated.
Assessment of heterogeneity
We would have assessed clinical and methodological diversity in
terms of participants, interventions, outcomes, and study charac-
teristics for the included studies in order to determine whether a
meta-analysis was appropriate. We would have conducted this by
observing these data from the data extraction tables. We would
have assessed statistical heterogeneity by visual inspection of the
forest plot for obvious differences in results between the studies,
and by using the I² and Chi² statistical tests.
We would have qualified inconsistency among pooled estimates
by using the I² statistic: ((Q - df )/Q) × 100% test, where Q was
the Chi² statistic and df represented the degree of freedom). This
would have examined the percentage of total variation across stud-
ies due to heterogeneity rather than to chance (Higgins 2003;
Higgins 2011).
We would have used these thresholds for interpretation of I²:
• 0% to 25%: low heterogeneity.
• 25% to 75%: moderate heterogeneity.
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• Greater than 75%: significant heterogeneity (Higgins
2003).
Assessment of reporting biases
Given the limited number of eligible trials available, we did not
create funnel plots to assess reporting biases. In future updates
of this review, we will interpret any funnel plot asymmetry with
caution.
Data synthesis
Methods of synthesizing studies depend on quality, design, and
heterogeneity. We would have explored both clinical and statisti-
cal heterogeneity. Where we considered studies to be sufficiently
similar, we would have conducted a meta-analysis by pooling ap-
propriate data using RevMan (RevMan 2014).
We assessed the quality of the evidence using the Grading
of Recommendations Assessment, Development and Evaluation
(GRADE 2015) approach and constructed ’Summary of findings
for the main comparison for the outcomes.
Subgroup analysis and investigation of heterogeneity
If we had found sources of heterogeneity, and when data were suf-
ficient, we had planned to conduct meta-analyses by subgroups. If
we had identified an adequate number of studies, we had planned
to performed subgroup analyses according to participant age, par-
ticipant sex, type of revascularization, degree of stenosis, and ini-
tial neurologic severity.
If we had identifiedno significant heterogeneity, we hadplanned to
compute pooled estimates of the treatment effect for each outcome
using a fixed-effect model. When we detected significant hetero-
geneity despite subgroup analyses, we would have calculated the
pooled estimate of treatment effects using random-effects models.
Sensitivity analysis
If an adequate number of studies had been identified, we had
planned to perform sensitivity analyses based on separation of
studies according to risk of bias. We would have done this by ex-
cluding trials that were most susceptible to bias, based on our risk
of bias assessment: those with inadequate allocation concealment,
high levels of post-randomization losses or exclusions, and uncer-
tain or unblinded outcome assessment (Deeks 2011).
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
Results of the search
We identified a total of 4255 articles, and after removing dupli-
cates, wemanually screened 3151 records.We identified six articles
from the search of theCochrane StrokeGroup’sTrialsRegister; two
reports of one study fulfilled the entry criteria (McCollum 2004).
There were no randomized clinical trials involving carotid percu-
taneous transluminal balloon angioplasty and stenting. Figure 1
depicts the process of study identification and selection.
Included studies
To date we have identified one completed randomized controlled
trial comparing very early cerebral revascularization with delayed
treatment for individuals with recently symptomatic carotid artery
stenosis (McCollum 2004). However, it compared very early
surgery with surgery performed after 14 days of the last symp-
tomatic event. Forty participants fit for surgery with partial an-
terior circulation infarction and a Barthel score greater than 18
within the preceding seven days and with 70% ipsilateral inter-
nal carotid stenosis were randomized into two surgical treatment
groups:
• very early surgery (within 24 hours); and
• late surgery (six to eight weeks).
Participants in the late surgery group received the bestmedical care
at the time, which consisted of antiplatelet therapy and rigorous
attention to the control of risk factors. Outcomes were assessed at
seven days, and two, six and 12 months following the surgery.
Excluded studies
Excluded studies were those that did notmeet the inclusion criteria
after we had reviewed the full text. We excluded three studies
because they were:
• confounded with no control group (Keunen 2012); or
• non-acute study (Ballota 2002, Sbatigia 2003); or
• not randomized (Keunen 2012, Sbatigia 2003).
Ongoing studies
There is one ongoing randomized trial that involves the timing
of cerebral revascularization (SPREAD-STACI). Correspondence
with the principal investigator indicated that a full publication is
planned in a few years.
10Immediate versus delayed treatment for recently symptomatic carotid artery stenosis (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Risk of bias in included studies
The included study was of very low methodological quality
(McCollum 2004). This study was classified as having a low risk
of bias for randomization, performance and reporting. It was also
classified as having an unclear risk of bias for detection and alloca-
tion concealment because the study did not provide any informa-
tion on this. We judged that the included study was at high risk
for attrition and small sample size biases (Figure 2).
Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
Allocation
Randomization of 40 participants with recently symptomatic
carotid artery stenosis was undertaken by computer. Although the
participants in the early group underwent surgery soon after ran-
domization, the time between the neurological event and the op-
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eration was not clear. According to the author, most of the partic-
ipants in the trial were operated on within a day or two of cere-
bral infarction. However, there were no available data on the pro-
portion who underwent surgery within 48 hours of the onset of
symptoms (personal communication).
Blinding
Due to the study design and the nature of the intervention and
outcomes, health workers and participants were not blinded to
treatment or outcome.
All the carotid endarterectomies were performed by the same vas-
cular surgeon, using a standard surgical technique. Participants
were followed up by the trial coordinator seven days after treat-
ment and then again at two, six, and 12 months following ran-
domization. No reference was made as to whether the outcome
assessor was blinded to the timing of surgery.
Incomplete outcome data
Of the 21 participants randomized to ’delayed’ surgery, nine par-
ticipants did not undergo carotid endarterectomy at two months.
Data were analyzed on an intention-to-treat basis. The included
study reported losses, and therefore, was classified as having a high
risk of attrition bias
Selective reporting
Outcome measures were recorded using the Barthel Activities of
Daily Living score for disability and the Modified Rankin Scale
for independence. All of the study’s pre-specified outcomes and all
expected outcomes of interest to the review were reported
Other potential sources of bias
We assessed possible bias by small size of the included study, as
small studies have been shown to overestimate treatment effects,
allowing critical criteria to be compromised.We considered studies
to be at low risk of bias if they had 200 participants or more per
arm, at unclear risk if they had 50 to 200 participants, and at
high risk if they had fewer than 50 participants (Dechartres 2013).
Therefore, we considered the included study was at high risk.
Effects of interventions
See: Summary of findings for the main comparison Very early
cerebral revascularization compared with delayed treatment for
recently symptomatic carotid artery stenosis
In the one included study, both study groups achieved an adequate
distribution of patient characteristics such as age, sex, and the
severity of carotid disease or stroke (McCollum 2004).
Nineteen participants were allocated to early surgery (usually
within two to six hours) and 21 to late surgery (six to eight weeks).
Outcome was determined 12 months after the stroke in this study.
Nine of the 21 participants randomized to the delayed group did
not undergo surgery due to occlusion of internal carotid following
randomization (three participants), participants refusal of surgery
(three participants), considered to bemedically unfit for surgery af-
ter stroke progression (two participants), and regression of carotid
stenosis to less than 70% (one participant).
We used a random-effects model because, after inclusion of future
studies, it is possible that the interventions themselves will differ
from one study to the next. The timing of the intervention, or the
’best medical therapy’ can be very different across time, as seen in
other studies (Ballota 2002; McCollum 2004).
Relative risks between early and late surgery did not attain statis-
tical significance for any of the outcomes assessed (see Data and
analyses). When we considered the cumulative unweighted risk of
stroke or death, or both, within 30 days of surgery, the risks for late
and early surgery were 5% (1/21) and 16% (3/19), respectively.
Three post-operative strokes were recorded in the early group and
none in the delayed group. Late surgery was favored, although
confidence intervals were wide (RR 3.32; 95% CI 0.38 to 29.23;
Analysis 1.1). However, when we considered the combined out-
come of perioperative death and strokes, the risks for the early and
delayed groups were 16% (3/19) and 33% (7/21), respectively.
Perioperative death rate was 5% in the delayed surgical group and
0% in the early group. In addition, six neurologic events were
recorded before surgery in the late group and none in the early
group. The relative risk between early and late surgery showed a
trend for better outcome in participants undergoing early surgery.
The benefits or hazards of early surgery in perioperative death and
stroke risks from these data remains unclear (RR 0.47; CI 0.14 to
1.58; Analysis 1.2).
The average length of hospital stay was 11 days for the early group
and 28 days for the delayed group. However, we were unable to
estimate 95% CIs of the difference due to the lack of standard
deviations.
D I S C U S S I O N
Summary of main results
Most studies that examine the influence of timing of cerebral revas-
cularization on outcomes after a neurological event are not ran-
domized. We identified only one completed, randomized study
that compared timing of surgery after a stroke, and there were not
enough data to draw any reliable conclusions about the preferred
timing of surgery (McCollum 2004). Hence there is a need for
further randomized trials.
There is one ongoing RCT that compares the timing of surgery
after an acute neurological event (SPREAD-STACI). The data
should be available within the next two years.
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Although the study compared very early surgery with surgery per-
formed after 14 days of the onset of symptoms, there is already
evidence that carotid endarterectomy performed within 14 days
of the symptoms produces better long-term results than if it is
delayed (Rothwell 2003). Therefore, it is unclear whether the risk
of stroke, death, or both in the delayed group was related to the
carotid surgery or to the conditions of the participants.
Overall completeness and applicability of
evidence
The primary outcome of this review, the combined outcome of
stroke, death, or both occurring within 30 days of intervention,
was poorly reported by the study, and the relative risks between
early and late surgery did not attain statistical significance. There-
fore, it was difficult to analyze and draw reliable conclusions.
Quality of the evidence
Overall, the included study was at a very high risk of bias. The
reasons for downgrading the quality of the evidence related to
the uncertainty in outcome measurement, the incompleteness of
outcome data available in the study, and a very small sample size.
The quality of all outcomes included in Summary of findings for
the main comparison was downgraded three levels, resulting in a
very low-quality of the evidence for all outcomes (GRADE 2015).
Another issue is that medical management has changed over the
study period, as more advanced pharmacological agents and more
stringent management of various risk factors of atherosclerosis
have led to an overall decline in the incidence of stroke.
Potential biases in the review process
We strived to prevent bias in the review process by involving two
independent review authors at each step of the review, and by
performing a comprehensive search with no language restrictions.
Agreements and disagreements with other
studies or reviews
We identified other systematic reviews that examined the timing of
interventions for recently symptomatic patients, which included
non-randomized clinical trials. They found no substantially ele-
vated risk with early surgery in stable patients (Rerkasem 2009),
but found an elevated risk in people with unstable neurological
symptoms (Naylor 2009; Rerkasem 2009).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is currently insufficient evidence to determine the relative
risks and benefits of very early cerebral revascularization. Optimal
periods of cerebral revascularization for recently symptomatic pa-
tients should be clarified. Until better evidence is available, the
choice of timing for surgery should depend on other sources of
information.
Implications for research
General
Little is known about the natural history of very recently symp-
tomatic carotid artery stenosis and what constitutes the best tim-
ing for treatment. Calculation of the sample size to verify the dif-
ference in efficacy of early and delayed surgery is difficult, due to
the lack of data. From observational studies, we can assume a cu-
mulative unweighted risk of perioperative stroke, death, or both
of 7.2% for carotid endarterectomy performed within 48 hours of
the onset of the initial ischemic symptom, and 18.1% for carotid
endarterectomy performed after 48 hours (Halm 2009; Johansson
2013; Sharpe 2013). Therefore, wewould need around 145 partic-
ipants in each arm for 80% power and 5% two-sided significance.
Considering possible dropouts of 10% over the whole study, the
required sample size in each study arm would be 160 participants.
Further studies, probably multicenter to obtain a larger sample,
are needed to consolidate this evidence.
Design
There is a need for further well conducted, prospective, random-
ized controlled trials (i.e. adequate randomization, allocation con-
cealment, blinding, etc), that assess the effects of timing of surgery
on participants with recently symptomatic carotid artery stenosis.
Aggressive treatment of vascular risk factors and antiplatelet ther-
apy must be promptly initiated because it is crucial to the pre-
vention of recurrent strokes Future studies should standardize the
observation time and stratify participants by age group, sex, grade
of ischemia, and degree of stenosis.
Measurement
The most important outcomes are the cumulative risk of strokes
and/or death before and within 30 days of surgery, and cumulative
risk of perioperative death and strokes.Other important issues that
require examination include patient age (do the elderly fare worse?
), grade of ischemia (major stroke), sex (male versus female), and
duration of hospitalizations.
A C K N OW L E D G E M E N T S
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
McCollum 2004
Methods Randomized
Multicenter
12 months follow-up
Intention-to-treat analysis
Participants 40 participants within 7 days of the onset of symptoms
Partial anterior circulation infarction
More than 70% ipsilateral carotid stenosis
Barthel score > 18
Interventions Early surgery (usually within 2 to 6 hours)
Late surgery (6 to 8 weeks)
Outcomes Outcome measures were recorded using Barthel Activities of Daily Living score for
disability and Modified Rankin scale for independence
Notes Study dates not reported
Nine of the 21 participants randomized to the late surgery group did not undergo surgery
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomized by computer
Allocation concealment (selection bias) Unclear risk Method not reported
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Blinding of study participants and person-
nel could not be done as 1 treatment group
had surgery arranged as soon as possible
while the other group did not
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk Allocation to the delayed surgical group
was retained in accordance with the ’inten-
tion-to-treat’ principle
Selective reporting (reporting bias) Low risk Data on pre-specified primary and sec-
ondary outcomes were presented
17Immediate versus delayed treatment for recently symptomatic carotid artery stenosis (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
McCollum 2004 (Continued)
Other bias High risk Size: sample size less than 50 per treatment
arm
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ballota 2002 Non-acute study (participants in the early group received carotid endarterectomy between 15 and 30 days)
Keunen 2012 Confounded with no control group; not randomized
Sbatigia 2003 Not randomized
Characteristics of ongoing studies [ordered by study ID]
SPREAD-STACI
Trial name or title SPREAD-STACI study
Methods Randomized
Multicenter
Blind follow-up at 90 days
Participants People presenting with TIA, amaurosis fugax or minor stroke within only a few hours of their first symptom
Stenosis ranging between 51% and 99% of the carotid artery
Interventions CEA within 48 hours or between 48 hours and 15 days from their initial ischemic symptom
Outcomes Primary outcome: any type of stroke, myocardial infarction, and death due to the procedures
Secondary outcome: ipsilateral stroke, identification of predictive risk factors, confirmation of the safety of
urgent CEA
Starting date 2010
Contact information Dr Gaetano Lanza - U.O. Chirurgia Vascolare, OspedaleMultiMedica, V.le Piemonte, 70, 21053 Castellanza
(Va)
Notes Size: 456 participants
CEA: carotid endarterectomy
TIA: transient ischemic attack
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D A T A A N D A N A L Y S E S
Comparison 1. Stroke
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Stroke and death < 30days 1 40 Risk Ratio (M-H, Random, 95% CI) 3.32 [0.38, 29.23]
2 Perioperative death and all
strokes
1 40 Risk Ratio (M-H, Random, 95% CI) 0.47 [0.14, 1.58]
C O N T R I B U T I O N S O F A U T H O R S
Protocol stage: draft the protocol EMKS, VV, NC, and JCCBS
Review stage: select which trials to include VV, NC, and EMKS
Review stage: extract data from trials VV and NC
Review stage: enter data into RevMan VV and NC
Review stage: carry out the analysis VV and EMKS
Review stage: interpret the analysis VV and EMKS
Review stage: draft the final review VV, EMKS, and JCCBS
Update stage: update the review VV, EMKS, and JCCBS
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Secondary outcomes in the protocol included “All strokes during the follow-up period and perioperative deaths”. In the review, we
defined ’perioperative’. In addition, we included “neurological events before surgery” in order to make a distinction between pre and
postoperative strokes.
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